HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 243 filers reported holding HORIZON PHARMA PLC in Q4 2016. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $4,394,000 | +35.7% | 166,217 | +0.3% | 0.05% | +14.3% |
| Q4 2018 | $3,239,000 | -0.2% | 165,734 | 0.0% | 0.04% | +35.5% |
| Q3 2018 | $3,245,000 | +18.2% | 165,734 | 0.0% | 0.03% | +14.8% |
| Q2 2018 | $2,745,000 | +16.7% | 165,734 | 0.0% | 0.03% | +12.5% |
| Q1 2018 | $2,353,000 | -8.8% | 165,734 | -6.2% | 0.02% | 0.0% |
| Q4 2017 | $2,581,000 | +15.2% | 176,748 | 0.0% | 0.02% | +33.3% |
| Q3 2017 | $2,241,000 | +4.7% | 176,748 | -2.0% | 0.02% | 0.0% |
| Q2 2017 | $2,140,000 | -22.3% | 180,275 | -3.3% | 0.02% | -25.0% |
| Q1 2017 | $2,754,000 | -7.2% | 186,354 | +1.6% | 0.02% | 0.0% |
| Q4 2016 | $2,967,000 | -17.7% | 183,383 | -7.7% | 0.02% | -14.3% |
| Q3 2016 | $3,604,000 | +159.1% | 198,762 | +135.4% | 0.03% | +133.3% |
| Q2 2016 | $1,391,000 | +139000.0% | 84,446 | +703616.7% | 0.01% | – |
| Q4 2015 | $1,000 | – | 12 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 5,664,219 | $83,717,000 | 10.14% |
| Consonance Capital Management LP | 6,218,903 | $91,915,000 | 9.63% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,944,988 | $161,767,000 | 6.24% |
| Rhenman & Partners Asset Management AB | 1,751,322 | $25,885,000 | 4.10% |
| SCOPIA CAPITAL MANAGEMENT LP | 9,686,262 | $143,163,000 | 2.64% |
| ARMISTICE CAPITAL, LLC | 850,000 | $12,563,000 | 2.59% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 2,959,258 | $43,738,000 | 2.40% |
| Proxima Capital Management, LLC | 246,311 | $3,640,000 | 2.22% |
| Beach Point Capital Management LP | 522,898 | $7,728,000 | 2.18% |
| GRAYBILL WEALTH MANAGEMENT, LTD. | 165,260 | $2,443,000 | 1.94% |